TP53 and urinary bladder cancer: The data suggest that TP53 and RAC1 are downregulated in bladder cancer and may likely contribute towards the development of NDV persistent infection in EJ28 cells; noting that TP53 was actually found to be upregulated in the established persistent EJ28Pi cells.